Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma

Fig. 2

Increased ACSL4 mRNA expression associated with poor overall survival in patients with CHOL. (A-B) OS, PFI in high and low ACSL4 group in TCGA-CHOL cohort. (C) The ROC curve analysis of ACSL4 in TCGA-CHOL cohort. (D-E) OS, DFS in high and low ACSL4 group in GSE107943 cohort. (F) The ROC curve analysis of ACSL4 in GSE107943 cohort. (G) OS of ACSL4 expression in meta-dataset. (H) The time-dependent ROC curve analysis of ACSL4 in meta-dataset. (I) OS of ACSL4 expression in our cohort

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us